Quantum Leap Logo with a gradient

The resources and support you need to leap cancer.

Cancer is a formidable opponent, but it’s never met the likes of us, your cancer fighting super group. With our incredible team of internal industry leading experts and world-class partners, we’re changing the game in patient treatment and care through our innovative, state-of-the-art clinical trials. From the latest research, to the everyday answers you want and need, we can help you navigate your journey with confidence.

OUR TRIALS

Learn more about our revolutionary clinical trials including locations where they are happening and how to enroll.

I-SPY 2 Trials

The I-SPY 2 Trial is an investigational drug trial for newly diagnosed patients with locally advanced breast cancer. An investigational drug has been approved for testing in people by the U.S. Food and Drug Administration (FDA) but has not yet been approved for widespread use. A clinical trial tests how well investigational drugs work and whether they are safe to use.
Learn More

Clinical Trial Matching

Did you know major advances in breast cancer cancer treatment and prevention have happened all because of breast cancer clinical trials? These research studies have saved countless lives and led to incredible advancements in treatments. Our trial matching tools, by BreastCancerTrials.org, are patient-centered and unbiased, designed to help you learn about and find trials that might be right for you.

Clinical Trial Navigator

Make an appointment with BreastCancerTrials.org’s Clinical Trial Nurse Navigator to get 1:1 support and guidance for using Breast Cancer Trial Search or Metastatic Trial Search to learn about and find trials that might be right for you.

FAQs

Helpful information to answer questions you may have.

Metastatic Trial Talk

Metastatic Trial Talk empowers you with knowledge about the latest clinical trials, research, and treatment options for you to share and discuss with your doctor.

Educational Resources for Patients

Cancer can bring up a lot of questions. Our curated list of resources for people affected by breast cancer can help you find information and support across a wide range of topics.

Clinical Trial Glossary

Visit the National Cancer Institute website for a comprehensive list of common terms related to cancer and clinical trials.

Meet our partners.

The innovative work we do wouldn’t be possible without our incredible network of partners from the healthcare industry and beyond.
Our Partners

Unsure if a clinical trial is right for? Hear what former participants have to say.

“If you’re reading this and have recently been given a cancer diagnosis, I’ve been there. A few years ago, I was standing where you are and unsure about what to do next. I’d never heard about clinical trials and wondered if they were right for me…”
Watch Video

News Coverage

A collection of announcements and press releases related to patients

Quantum Leap Healthcare Collaborative Initiates Landmark Phase 2 RECAST DCIS Platform Trial to Evaluate Alternative DCIS Treatments with Atossa Therapeutics, Havah Therapeutics, and the Menarini Group

40-site U.S. trial enrolling more than 300 patients could significantly change the way DCIS is treated and reduce possibly unnecessary surgery

Arvinas and Quantum Leap Healthcare Announce Clinical Study to Evaluate Vepdegestrant (ARV-471) in I-SPY-2 Endocrine Optimization Platform (EOP) Clinical Trial

Quantum Leap Healthcare Collaborative™ today announced that Arvinas’ vepdegestrant (ARV-471), a novel PROTAC® estrogen receptor (ER) protein degrader being co-developed with Pfizer Inc. will be evaluated in the ongoing I-SPY TRIAL endocrine program sponsored by Quantum Leap.

Quantum Leap Healthcare Collaborative Announces Mobile Platform Launch of its Clinical Trial Matching Service

Quantum Leap Healthcare Collaborative (QLHC) announces the mobile responsive launch of its metastatic breast cancer clinical trial matching service, Metastatic Trial Search (MTS). This launch expands MTS's reach to a broader range of breast cancer patient groups with a goal of reaching a more diverse population including those under-represented in clinical trials.

Exai Bio and Quantum Leap Healthcare Collaborative Announce Expanded Participation in I-SPY 2 Trial to Advance Exai’s Novel RNA-based Liquid Biopsy Platform in Breast Cancer

Exai Bio today announced a collaboration agreement with Quantum Leap Healthcare Collaborative™ (QLHC) to expand the use of Exai’s novel, RNA-based liquid biopsy platform to monitor patients’ treatment response and disease burden in the I-SPY 2 TRIAL. I-SPY2 is the largest and longest-running 'platform' trial that provides a regulatory framework to study multiple novel therapeutic treatment arms for women with newly diagnosed, locally advanced breast cancer. 

ALL QLHC IN THE NEWS

Dictionary of Cancer Terms

Find easy-to-understand definitions of terms related to cancer and medicine.

Go to Dictionary
© Quantum Leap Healthcare Collaborative. 2023-2024.

For Patients

For Investigators

Partnerships

About us

Trials
Resources
Contact Us
Donate

For Patients

For Investigators

Partnerships

About us

Studies
Collaborations
Publications
Contact Us
Donate
Investigators Portal

For Patients

For Investigators

Partnerships

About us

Partnerships
One Source
Donate

For Patients

For Investigators

Partnerships

About us

Our Approach
QLHC in the News
Working at QL
Contact Us
Donate